Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Immunomedics Inc (NASDAQ:IMMU) shares are trading higher on Tuesday, after Barclays initiated coverage on the company's stock with an Overweight rating and $40 price target.
Immunomedics is a clinical-stage biopharmaceutical company, based in the U.S. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others.
Immunomedics shares trading up 3.63% at $6.57 on Tuesday. The stock has a 52-week range between $8.92 and $3.26.
Related Links:
Roche's Faster Coronavirus Test Receives FDA Emergency Use Authorization
Gilead's Remdesivir Granted FDA Emergency Use To Treat COVID-19
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!